Clinical trial
Studying Genes to Identify Melanoma in Patients in Iceland and Their Family…
NCT00346008 · Iceland Genomics Corporation, Industry · Completed
Key facts
| NCT number | NCT00346008 |
|---|---|
| Title | Studying Genes to Identify Melanoma in Patients in Iceland and Their Family Members |
| Official title | Genetic Epidemiologic Studies of Melanoma in Iceland |
| Lead sponsor | Iceland Genomics Corporation, Industry |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Melanoma (Skin) |
| Intervention type | Genetic, Other |
| Interventions | mutation analysis, high performance liquid chromatography, laboratory biomarker analysis, questionnaire administration |
| Enrollment | 2,500 |
| Start date | Oct 1, 2005 |
| Primary completion | Dec 1, 2008 |
| Completion | Feb 1, 2009 |
| First posted | Jun 29, 2006 |
| Last update posted | May 30, 2013 |
| Countries | Iceland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: